An outpatient case study of Cyaplex F: mitigated adverse effects associated with Imatinib

Sun L Riehm (임성락)

An outpatient case study of Cyaplex F: mitigated adverse effects associated with Imatinib

CELLMED
Abbr : CellMed
2023, 13(12), pp.1~7
Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
Research Area : Medicine and Pharmacy > General Medicine
Received : September 27, 2023
Accepted : September 27, 2023
Published : September 30, 2023

Sun L Riehm ¹

¹Indiana University Health

Irregular Papers

ABSTRACT

Objective: A case of reducing adverse effects associated with imatinib using Cyaplex F. Methods: The 52-year-old female with past medical history of stage 1 triple-positive breast cancer 10 years ago, and current metastatic melanoma has been complaining adverse effects after imatinib was started. Results: After OCNT was initiated, the patient’s headache and muscle pain have been much tolerable and her AST/CPK levels were returned close to her baseline. Conclusion: OCNT may reduce side effects caused by Imatinib and help patient to stay with the current chemotherapy regimen.

KEYWORDS

Ortho-Cellular Nutrition Therapy (OCNT), breast cancer, melanoma, headache, muscle pain, AST, CPK

Journal Copyright Policy

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.

Citation status

* References for papers published after 2025 are currently being built.

[journal] Waks, A. G. / 2019 / Breast cancer treatment: a review 321 : 288~300

[journal] Yager, J. D. / 2006 / Estrogen carcinogenesis in breast cancer / J. N. E. J. o. M 354 : 270~282

[journal] Ciarletta, P / 2011 / The radial growth phase of malignant melanoma: multi-phase modelling, numerical simulations and linear stability analysis / J. J. o. t. R. S. I 8 : 345~368

[journal] Syn, N. L / 2017 / De-novo and acquired resistance to immune checkpoint targeting / J. T. L. O 18 : e731~e741

[journal] Choi, E / 2000 / The comparison of histological effects of musk containing and civet containing WooHwangChungSimWon on the cerebral ischemia / J. J. A. P 8 : 255~261

[journal] Green, K. N / 2020 / To kill a microglia: a case for CSF1R inhibitors / J. T. i. i 41 : 771~784

[journal] 문세환 / 2020 / The M-CSF receptor in osteoclasts and beyond / Experimental and Molecular Medicine / 생화학분자생물학회 52 : 1~16

[journal] Yang, G / 2013 / Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs / J. P. & therapeutics 139 : 392~404

[journal] Breyer‐Pfaff, U. / 2004 / The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man / J. D. m. r 36 : 723~746

[journal] Wang, B. / 2009 / New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme 41 : 573~643

[journal] Anderson, B. M / 2009 / Are all n-3 polyunsaturated fatty acids created equal? / J. L. i. h. & Disease 8 : 1~20

[journal] Mori, N / 2012 / Beneficial effects of fucoidan in patients with chronic hepatitis C virus infection / J. W. j. o. g. W 18 : 2225~

[journal] Toufektsian, M.-C. / 2008 / Chronic dietary intake of plant-derived anthocyanins protects the rat heart against ischemia-reperfusion injury 138 : 747~752

[journal] Kedzierska, M / 2012 / Effects of the commercial extract of aronia on oxidative stress in blood platelets isolated from breast cancer patients after the surgery and various phases of the chemotherapy 83 : 310~317

[journal] Wang, H. / 1999 / Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries 62 : 294~296

[journal] Kamei, H. / 1995 / Suppression of tumor cell growth by anthocyanins in vitro 13 : 590~594

KJCKorea
Journal Central

CELLMED 2025 KCI Impact Factor : 0.18